Objectives
•Definitions
•Benefits and Possible harms of developmental surveillance and screening
•Combining Screening and Surveillance Practice Algorithm
advanced role of nurse practitioner
Define preoperative nursing and operating room nurse.
Describe phases of the preoperative period.
Describe the physical environment of the OR.
Show specific areas within the operating room (OR).
Locate and describe the use of furniture and equipment in the operating room.
Identify the role of each member of the operating room team.
Discuss how environmental layout contributes to aseptic technique.
Perioperative nursing care is crucial in ensuring the well-being and safety of patients throughout the entire surgical process.
It requires a high level of skill, knowledge, and attention to detail.
play a vital role in promoting positive surgical outcomes and providing patients with the support and care they need during this vulnerable time.
A brief research overview connecting parenting education with health related outcomes for children and families. Created by the Parenting Education team at Oregon State University with funding from the Oregon Parenting Education Collaborative.
advanced role of nurse practitioner
Define preoperative nursing and operating room nurse.
Describe phases of the preoperative period.
Describe the physical environment of the OR.
Show specific areas within the operating room (OR).
Locate and describe the use of furniture and equipment in the operating room.
Identify the role of each member of the operating room team.
Discuss how environmental layout contributes to aseptic technique.
Perioperative nursing care is crucial in ensuring the well-being and safety of patients throughout the entire surgical process.
It requires a high level of skill, knowledge, and attention to detail.
play a vital role in promoting positive surgical outcomes and providing patients with the support and care they need during this vulnerable time.
A brief research overview connecting parenting education with health related outcomes for children and families. Created by the Parenting Education team at Oregon State University with funding from the Oregon Parenting Education Collaborative.
Child-health practitioners in Iowa must find better ways to address family, neighborhood and economic factors that shape children' health and well being, according to CFPC executive director Charles Bruner and Debra Waldron, director and chief medical officer of the Child Health Specialty Clinics at the University of Iowa. They presented at the Iowa Governor's Conference on Public Health in Ames on April 5.
ISPCAN Jamaica 2018 - The Impact of Domestic Violence on Children's Functioni...Christine Wekerle
The Impact of Domestic Violence on Children's Functioning: Care Planning Approaches to Foster Trauma-Informed Care
Shannon Stewart, Yasmin Garad, Natalia Lapshini
approach to child with immunedeficiency Aug 2018.pptxOlaAlkhars
immunodeficiency presents with increased susceptibility to infection but may also manifest with conditions that reflect dysregulation of the immune response, such as allergies, autoimmunity, or lymphoproliferation
Child-health practitioners in Iowa must find better ways to address family, neighborhood and economic factors that shape children' health and well being, according to CFPC executive director Charles Bruner and Debra Waldron, director and chief medical officer of the Child Health Specialty Clinics at the University of Iowa. They presented at the Iowa Governor's Conference on Public Health in Ames on April 5.
ISPCAN Jamaica 2018 - The Impact of Domestic Violence on Children's Functioni...Christine Wekerle
The Impact of Domestic Violence on Children's Functioning: Care Planning Approaches to Foster Trauma-Informed Care
Shannon Stewart, Yasmin Garad, Natalia Lapshini
approach to child with immunedeficiency Aug 2018.pptxOlaAlkhars
immunodeficiency presents with increased susceptibility to infection but may also manifest with conditions that reflect dysregulation of the immune response, such as allergies, autoimmunity, or lymphoproliferation
Antibiotic therapy for chronic pulmonary infection in Cystic.pdfOlaAlkhars
Prevalence of bacteria identified in respiratory secretions from patients with CF , by age cohort
Consequences of Chronic infection with P. Aeruginosa and MRSA
PERIODIC SURVEILLANCE CULTURES
Antibiotics for Treatment of acute pulmonary exacerbations
Early eradication of MRSA
Prevention of acquisition of chronic airways infection
Diagnosis and Management of Cow’s Milk Protein Allergy OlaAlkhars
AIMS AND OBJECTIVES
1- Classification of adverse milk reaction
2- Consider the prevalence of Cow’s Milk Protein Allergy (CMPA) and challenges of diagnosis
3- Review the differences between IgE and non-IgE CMPA
4- Consider What advice should be given to those with IgE mediated CMPA
And how to manage non-IgE CMPA, Considering types of formula and milk Ladder
British guidance for screening for uveitis in JIA
•European recommendation for management of uveitis in JIA
•Diagnosis and screening in JIA-related uveitis
•Disease activity measurement in JIA associated uveitis
•Treatment in JIA-associated uveitis
•Definition of treatment failure
•Future plans in JIA-related uveitis
Optimizing nutrition and growth for children with special Health care needs ...OlaAlkhars
Learning objectives
• Bone Growth Regulation and pattern
• Optimizing Nutrition And Bone Health in Children with Cerebral Palsy
• Developmental stages in child feeding
• Picky Eaters vs Avoidant/Restrictive Food Intake Disorder (ARFID)
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
2. Objectives
• Definitions
• Benefits and Possible harms of developmental surveillance and
screening
• Combining Screening and Surveillance Practice Algorithm
3. To provide a framework
evidence-based
Practical Algorithm for
Combining Screening
and Surveillance for
early identification and
Intervention for child
with DD
4. Development
Process of functional maturation of individual
Progressive increase in skills & capacity to function
Related to maturation & myelination of the CNS
Includes psychosocial, emotional, social, cognitive changes
5.
6.
7. Questions should be answered for any Child with DD
• Static or progressive developmental disorder?
• What type of developmental issue?
• Global, motor, language, social
• What is the current developmental level of the child ?
• Possible timing? (prenatal/perinatal/postnatal)
• Is there a likely underlying etiology?
• structural, genetic, birth related
• What are the current therapy/rehabilitative needs of the patient ?
8.
9. Diagnostic criteria
Bélanger SA, Caron J. Evaluation of the child with global developmental delay and intellectual disability. Paediatr Child Health. 2018;23(6):403-419. doi:10.1093/pch/pxy093
10. Diagnostic criteria
Bélanger, Stacey A, and Joannie Caron. “Evaluation of the child with global developmental delay and intellectual disability.” Paediatrics & child health vol. 23,6
(2018): 403-419. doi:10.1093/pch/pxy093
11. Definitions
Surveillance
• process of
recognizing
children who may
be at risk
Screening
• use of
standardized
tools to identify
those children at
risk
Evaluation
• complex process
aimed at
identifying
specific
developmental
disorders
12. BENEFITS OF SURVEILLANCE AND SCREENING
Early
Identification
Early Intervention
Earlier Rx of
underlying medical
conditions
Improved
outcomes
13. BENEFITS OF EARLY INTERVENTION
Decreased need for special education services during the school years
Higher graduation rates
Higher employment rates
Decrease in criminal behavior and violence
Benefits sustained for 15 to 49 years after the intervention .
14. BENEFITS FOR CAREGIVERS
Increased numbers of caregivers reporting that their concerns were addressed
and questions answered .
permits them to better match their expectations to their child's abilities
To provide developmentally appropriate activities and stimulation
To feel that they are doing all that they can to assist their child .
Opportunity to avert secondary problems such as self-esteem, self confidence.
15. PERCEIVED HARMS OF SURVEILLANCE AND SCREENING
False positive results
• Unnecessary developmental
evaluation
• Undue anxiety for caregivers
• Stigma for the child
False negative results
• Under-referral or delayed
referral to early intervention
services.
16. PERCEIVED BURDENS OF SURVEILLANCE AND SCREENING
• Additional time
• Additional documentation
17. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
AAP, American Academy of Pediatrics; IDEA, Individuals with Disabilities Education Act; PEDS:DM, Parents’ Evaluations of Developmental Status:
Developmental Milestones.
18. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL SOURCES AND
FOLLOW UP WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
AAP, American Academy of Pediatrics; IDEA, Individuals with Disabilities Education Act; PEDS:DM, Parents’ Evaluations of Developmental Status:
Developmental Milestones.
19. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND
PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-
BEHAVIORAL SCREENING TEST(S) FOCUSED ON
MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR)
ADDITIONAL MENTAL HEALTH SCREENS.
20. • A medical home is an approach
to providing comprehensive
primary care that facilitates
partnerships between patients,
clinicians, medical staff, and
families.
• Extends beyond the four walls
of a clinical practice.
• It includes specialty care,
educational services, family
support and more.
21. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
22. Why are we search for the aetiology ?
• Prognostication
• Prevention (associated conditions)
• Ends the diagnostic journey/limits unnecessary testing
• Recurrence risk
• Closure/family empowerment
24. Developmental Delay/Disability
• There is enormous psychological, emotional, and economic impact on
the affected individuals and society
• Prevalence: It is estimated 1-3%
• It is probably higher in Saudi Arabia
25. Habibullah H, Albradie R, Bashir S. Identifying pattern in global developmental delay children: A retrospective study at King Fahad specialist hospital, Dammam (Saudi
Arabia). Pediatr Rep. 2019 Dec 2;11(4):8251. doi: 10.4081/pr.2019.8251. PMID: 31871607; PMCID: PMC6908955.
26.
27.
28.
29.
30. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
31. PSYCHOSOCIAL RISK FACTORS
- Adverse childhood or family experiences
- Parental/caregiver unemployment or mental health problems
- Parents/caregivers with limited education/literacy
- Teenage parents
32. Protective/Resilience factors
• Strong connections within a loving, supportive family
• Active caregiver-child engagement
• Opportunities to interact with other children
• Opportunities to grow in independence in an environment with
appropriate structure
33. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
34.
35. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
40. • Parent or caregiver-completed screening
tools that encourage parent/caregiver
involvement
• Tools to accurately identify children at
risk for developmental or social-
emotional delay
• Tools to educate adults about child
development and guide developmental
promotion
41.
42. Features : ASQ-3 Intervals
2,4,6,8,9,10,12,14,16,18,20,22,24
27,30,33,36
42,48,54,60,66
Recommendations:
Monitor every 4-6 months up to 2 years
Monitor every 6 months after 2 years
Monitor more frequently if concerned
43. Features : ASQ-3 cover page
• Administration window
indicated on the cover page
• 16 months “window” is for
children ages 15 months 0 days
through 16 months 30 days
50. M-CHAT
An autism-specific screen (e.g., M-CHAT [Modified Checklist for Autism in Toddlers]).
Use of previsit, parent-completed tools is particularly efficient.
51.
52.
53.
54.
55.
56. Combining Screening and Surveillance:
a Practice Algorithm
1. ENSURE A MEDICAL HOME.
2.REVIEW MEDICAL CHART FOR HEALTH RISK FACTORS.
3. IDENTIFY AND MONITOR PSYCHOSOCIAL RISK AND PROTECTIVE FACTORS.
4. ELICIT AND ADDRESS PARENTS’ CONCERNS.
5. ADMINISTER AND SCORE DEVELOPMENTAL-BEHAVIORAL SCREENING TEST(S)
FOCUSED ON MILESTONES.
6. IF INDICATED, ADMINISTER (OR REFER FOR) ADDITIONAL MENTAL HEALTH
SCREENS.
57.
58. Indications for mental health screening
Psychosocial concerns identified by the caregivers
Family disruption
Poor school performance
Behavioral difficulty
Recurrent somatic complaints
Involvement of a social service
59. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL SOURCES AND FOLLOW UP
WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
60. Physical Examination
• Children should kept in close proximity to the parents
• Leave the more intrusive ( hands on ) aspects of the exam until the end
• Social interaction with parents & examiner
61. • Observations : Stand and look don't disturb , just give look for 30 sec.
for
• Dysmorphic pictures , gait and balance , left handed or right handed.
62. General physical examination
• Growth parameters
• Head shape and circumference
• Eye findings (e.g., cataracts in various IEM)
• Birth marks, vascular markings, and Wood lamp examination
• Spine
• Examine closely for findings consistent with abuse/neglect
• Hepatosplenomegaly
63. • Mental status
• Motor function
• Sensory exam.
• Evaluation of the cranial nerves.
64. Developmental Evaluation
• Rapport : Go to the child level and try to play with him.
• Demonstrate for him and ask to do a MOTOR DEVELOPMENTALN TASKS:
• GROSS MOTORM (stand /walk/run/jump/climb stairs/Ball )
• FINE MOTOR AND VISON (Cubes/Crayon and paper/Scissors and paper/Beads and threads/
pictures Book/Board/Pincer grip)
• HEARING / SPEECH ASSESSMENT AND COGNITION:
• Name , age, sex, address and ask him to count from 1-10
• Say and understanding of words/sentences structure
• Identify body parts or colors
• Assess concentration and attention
• Assess picture recognition and selection
• ASSESSMENT OF SOCIAL MILESTONES: (ask parent)
• Feeding
• Play (Solitary/Spectator/Parallel/Associate/Co-operative)
• Caring /Dressing
65. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL SOURCES AND FOLLOW UP
WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
68. EEG and neuroimaging
INDICATIONS:
• clinical suspicion of a seizure disorder
• Hydrocephalus
• Micro- or macrocephaly
• Encephalopathy
• Neurofibromatosis
• Tuberous sclerosis
• Focal Neurological defiecit
• Extreme handedness at an early age
• persistence of fisting after 4 months
• Other neurological problem (not including autism)
69. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL
TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND
FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL
SOURCES AND FOLLOW UP WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
70. • The primary medical provider should present the screening
results to parents in person.
• Results should be explained in a positive manner
• Asking the parents if they know any families with children who
have developmental differences may be helpful in
understanding any strong reaction to the information being
presented.
• Offers to re-explain findings to other family members may be
needed.
71. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL
TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND
FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL
SOURCES AND FOLLOW UP WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
72. • Referral forms or letters, which target the areas of concern
• speech-language therapy,
• Occupational and physical therapy
• Social-emotional assessment
• Intelligence testing, academics
73. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL
TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND
FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL
SOURCES AND FOLLOW UP WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
74. • Some parents wish to try at-home interventions.
• Other parents get “cold feet” and may be deterred by differing opinions from relatives (e.g.,
“His father was just like that” ; “It is a phase. She’ll grow out of it.”).
• A follow-up appointment in 3-4 months is helpful for encouraging families, and, if needed,
at least advising parents to visit the programs recommended.
• Note that ambiguous concerns such as “I think he’s doing better” still convey
substantial risk.
75. Combining Screening and Surveillance:
a Practice Algorithm
7. PROVIDE PHYSICAL EXAMINATION AND CLINICAL OBSERVATION.
8. WHEN INDICATED, PLAN AND REFER FOR ADDITIONAL MEDICAL TESTS.
9. EXPLAIN SCREENING RESULTS TO PARENTS.
10. MAKE REFERRALS FOR NONMEDICAL INTERVENTIONS AND FOLLOWING UP.
11. REVIEW REPORTS AND OTHER FEEDBACK FROM REFERRAL SOURCES AND FOLLOW UP
WITH FAMILIES
12. PROVIDE DEVELOPMENTAL-BEHAVIORAL PROMOTION.
76. • Providing written patient education materials
• When screening and surveillance methods do not identify a need for nonmedical
interventions, the need to address “the normal problems of normal children”
remains.
• All parents need advice about typical problems
• All parents need to be encouraged to promote their child’s language and
preacademic/academic development.
• Follow up with families, in 6-8 weeks to assess the effectivenesss of promotion
activities.
77.
78.
79. • All patients with DD/LD need a comprehensive medical evaluation
by complete medical Hx, P/E
• Development assessment by using standardized development
assessment scales.
• If the clinical diagnosis is obvious or suspected, confirm the
diagnosis with appropriate genetic testing.
80. • If diagnosis is unknown and no clinical diagnosis is strongly suspected, begin in stepwise
evaluation by: chromosomal microarray; Fragile X testing; for females complete MECP2
• Whether diagnosed or not, results and their implications should be carefully explained
to the parents/care givers.
• Appropriate support should be made.